000 01578 a2200433 4500
005 20250516104708.0
264 0 _c20130321
008 201303s 0 0 eng d
022 _a1875-533X
024 7 _a10.2174/092986712803306466
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGiannubilo, S R
245 0 0 _aAnticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia.
_h[electronic resource]
260 _bCurrent medicinal chemistry
_c2012
300 _a4562-71 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aAspirin
_xadverse effects
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBreast Feeding
650 0 4 _aChondroitin Sulfates
_xadverse effects
650 0 4 _aDermatan Sulfate
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFondaparinux
650 0 4 _aHeparin
_xadverse effects
650 0 4 _aHeparin, Low-Molecular-Weight
_xadverse effects
650 0 4 _aHeparitin Sulfate
_xadverse effects
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aPolysaccharides
_xadverse effects
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications, Hematologic
_xdrug therapy
650 0 4 _aThromboembolism
_xdrug therapy
650 0 4 _aThrombophilia
_xetiology
650 0 4 _aWarfarin
_xadverse effects
700 1 _aTranquilli, A L
773 0 _tCurrent medicinal chemistry
_gvol. 19
_gno. 27
_gp. 4562-71
856 4 0 _uhttps://doi.org/10.2174/092986712803306466
_zAvailable from publisher's website
999 _c22011242
_d22011242